Effects of duloxetine on norepinephrine and serotonin transporter activity in volunteers

Trial Profile

Effects of duloxetine on norepinephrine and serotonin transporter activity in volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Apr 2014

At a glance

  • Drugs Duloxetine (Primary)
  • Indications Back pain; Depressive disorders; Fibromyalgia; Generalised anxiety disorder; Major depressive disorder; Musculoskeletal pain; Neuropathic pain; Stress incontinence; Urinary incontinence
  • Focus Pharmacodynamics
  • Sponsors Eli Lilly
  • Most Recent Events

    • 07 Apr 2014 New trial record
    • 01 Apr 2014 Results published in the Journal of Clinical Psychopharmacology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top